Posts Tagged ‘Government Approval’

  • Oakajee Port Gets Government Approval

    Sunday, March 22nd, 2009

    Murchison Metals Limited (MMX) announces that the Premier of Western Australia, the Honourable Colin Barnett, MLA today signed a State Development Agreement with Oakajee Port & Rail (OPR) for the Oakajee port and rail infrastructure project. Murchison and Mitsubishi Development Pty Ltd (Mitsubishi), a subsidiary of Mitsubishi Corporation of Japan, each hold a 50% interest in OPR which will deliver a world-class open access infrastructure solution for the emerging resources industry in Western Australia’s mid-west. 

    The WA Government has also committed to invest directly in the construction of the common user portion of the port at Oakajee, 25 kilometres north of the mid-west city of Geraldton. The Government has estimated the capital cost of the outer harbour construction at $678 million and has made a request to the Federal Government to contribute 50% of this capital cost through Infrastructure Australia. 

    Murchison Executive Chairman Paul Kopejtka welcomed the signing of the State Development Agreement as a major step forward for the Oakajee infrastructure project and the expansion of Murchison’s iron ore mining business in the mid-west. “Today’s execution of the State Development Agreement for the Oakajee project represents a major milestone in the development of both our infrastructure and mining businesses,” said Mr Kopejtka. “The certainty delivered by the Agreement also allows all other miners in the mid-west region to now proceed with their own expansion projects.  

    http://www.mml.net.au/   

    Post to Twitter

    SciGen Approved to Sell Insulin in China

    Tuesday, March 3rd, 2009

    SciGen Limited (SIE) announced today that the company has secured the health registration and marketing authorization for the sale and distribution of SciGen’s recombinant human Insulin, SciLin, throughout the People Republic of China. 

    The long awaited health registration will allow SciGen distributor Shenzhen Meheco and Hefei Life Sciences technology (HLST) to engage in promotional activities thru other distribution partners in China to ensure in-depth coverage in all Chinese provinces. The agreement requires Shenzhen Meheco & HSLT to sell SciGen’s recombinant human insulin on an exclusive basis during the 7 year term. Sales are expected to begin in the second quarter of this year. 

    In China, SciGen expects to generate sales revenues of US$17 million dollars over the next three years with its recombinant human Insulin. The agreement with Shenzhen Meheco / HSLT, containing minimum order provisions, forms the basis of SciGen expectations. 

    http://www.scigenltd.com/

    Post to Twitter